Paul Morton

Principal Data Scientist
Genentech, Inc.

Presentation(s):

• OC 40.4 - Safety and Efficacy of Emicizumab in People with Hemophilia A Enrolled in the Hemophilia Natural History Study (ATHN 7)

  Monday, July 11, 2022
  3:30 PM – 3:45 PM